Advanced search
1 file | 363.55 KB

Monoclonal antibody 14C5 targets integrin alpha(v)beta(3)

(2008) MOLECULAR CANCER THERAPEUTICS. 7(12). p.3771-3779
Author
Organization

Downloads

    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 363.55 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Burvenich, Ingrid, Steve Schoonooghe, Liesbet Vervoort, Caroline Dumolyn, Elisabeth Coene, Lieve VANWALLEGHEM, Jacques Van Huysse, et al. 2008. “Monoclonal Antibody 14C5 Targets Integrin Alpha(v)beta(3).” Molecular Cancer Therapeutics 7 (12): 3771–3779.
APA
Burvenich, Ingrid, Schoonooghe, S., Vervoort, L., Dumolyn, C., Coene, E., VANWALLEGHEM, L., Van Huysse, J., et al. (2008). Monoclonal antibody 14C5 targets integrin alpha(v)beta(3). MOLECULAR CANCER THERAPEUTICS, 7(12), 3771–3779.
Vancouver
1.
Burvenich I, Schoonooghe S, Vervoort L, Dumolyn C, Coene E, VANWALLEGHEM L, et al. Monoclonal antibody 14C5 targets integrin alpha(v)beta(3). MOLECULAR CANCER THERAPEUTICS. 2008;7(12):3771–9.
MLA
Burvenich, Ingrid, Steve Schoonooghe, Liesbet Vervoort, et al. “Monoclonal Antibody 14C5 Targets Integrin Alpha(v)beta(3).” MOLECULAR CANCER THERAPEUTICS 7.12 (2008): 3771–3779. Print.
@article{446316,
  author       = {Burvenich, Ingrid and Schoonooghe, Steve and Vervoort, Liesbet and Dumolyn, Caroline and Coene, Elisabeth and VANWALLEGHEM, Lieve and Van Huysse, Jacques and Praet, Marleen and Cuvelier, Claude and Mertens, Nico and De Vos, Filip and Slegers, Guido},
  issn         = {1535-7163},
  journal      = {MOLECULAR CANCER THERAPEUTICS},
  language     = {eng},
  number       = {12},
  pages        = {3771--3779},
  title        = {Monoclonal antibody 14C5 targets integrin alpha(v)beta(3)},
  url          = {http://dx.doi.org/10.1158/1535-7163.MCT-08-0600},
  volume       = {7},
  year         = {2008},
}

Altmetric
View in Altmetric
Web of Science
Times cited: